Global Warfarin Market Growth 2024-2030

Publication ID:

LPI08247911

Publication Date:

August 23, 2024

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

This report studies Warfarin Drugs market.
The global Warfarin market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淲arfarin Industry Forecast鈥� looks at past sales and reviews total world Warfarin sales in 2023, providing a comprehensive analysis by region and market sector of projected Warfarin sales for 2024 through 2030. With Warfarin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Warfarin industry.
This Insight Report provides a comprehensive analysis of the global Warfarin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Warfarin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Warfarin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Warfarin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Warfarin.
United States market for Warfarin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Warfarin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Warfarin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Warfarin players cover Qilu Pharma, Sine Pharma (Shanghai Pharma), Beijing Jialin Pharmaceutical, Henan Zhongjie Pharma and Shanghai Xudong Haipu Pharmaceutical (SunRise), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Warfarin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
1mg/Tablet
2.5mg/Tablet
3mg/Tablet
5mg/Tablet
Others
Segmentation by application
Mechanical Heart Valves (MHV) Replacement
Atrial Fibrillation (AF)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Qilu Pharma
Sine Pharma (Shanghai Pharma)
Beijing Jialin Pharmaceutical
Henan Zhongjie Pharma
Shanghai Xudong Haipu Pharmaceutical (SunRise)
Amneal Pharma
TEVA (Barr, PLIVA)
Cipla (InvaGen)
Orion Corporation Orion Pharma
BRISTOL MYERS SQUIBB
UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
Zydus Pharmaceuticals (USA) Inc
Taro Pharmaceutical Industries Ltd.
IPCA LABS LTD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Warfarin market?
What factors are driving Warfarin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Warfarin market opportunities vary by end market size?
How does Warfarin break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Warfarin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Warfarin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Warfarin by Country/Region, 2019, 2023 & 2030
2.2 Warfarin Segment by Type
2.2.1 1mg/Tablet
2.2.2 2.5mg/Tablet
2.2.3 3mg/Tablet
2.2.4 5mg/Tablet
2.2.5 Others
2.3 Warfarin Sales by Type
2.3.1 Global Warfarin Sales Market Share by Type (2019-2024)
2.3.2 Global Warfarin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Warfarin Sale Price by Type (2019-2024)
2.4 Warfarin Segment by Application
2.4.1 Mechanical Heart Valves (MHV) Replacement
2.4.2 Atrial Fibrillation (AF)
2.4.3 Deep Vein Thrombosis (DVT)
2.4.4 Pulmonary Embolism (PE)
2.4.5 Others
2.5 Warfarin Sales by Application
2.5.1 Global Warfarin Sale Market Share by Application (2019-2024)
2.5.2 Global Warfarin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Warfarin Sale Price by Application (2019-2024)
3 Global Warfarin by Company
3.1 Global Warfarin Breakdown Data by Company
3.1.1 Global Warfarin Annual Sales by Company (2019-2024)
3.1.2 Global Warfarin Sales Market Share by Company (2019-2024)
3.2 Global Warfarin Annual Revenue by Company (2019-2024)
3.2.1 Global Warfarin Revenue by Company (2019-2024)
3.2.2 Global Warfarin Revenue Market Share by Company (2019-2024)
3.3 Global Warfarin Sale Price by Company
3.4 Key Manufacturers Warfarin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Warfarin Product Location Distribution
3.4.2 Players Warfarin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Warfarin by Geographic Region
4.1 World Historic Warfarin Market Size by Geographic Region (2019-2024)
4.1.1 Global Warfarin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Warfarin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Warfarin Market Size by Country/Region (2019-2024)
4.2.1 Global Warfarin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Warfarin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Warfarin Sales Growth
4.4 APAC Warfarin Sales Growth
4.5 Europe Warfarin Sales Growth
4.6 Middle East & Africa Warfarin Sales Growth
5 Americas
5.1 Americas Warfarin Sales by Country
5.1.1 Americas Warfarin Sales by Country (2019-2024)
5.1.2 Americas Warfarin Revenue by Country (2019-2024)
5.2 Americas Warfarin Sales by Type
5.3 Americas Warfarin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Warfarin Sales by Region
6.1.1 APAC Warfarin Sales by Region (2019-2024)
6.1.2 APAC Warfarin Revenue by Region (2019-2024)
6.2 APAC Warfarin Sales by Type
6.3 APAC Warfarin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Warfarin by Country
7.1.1 Europe Warfarin Sales by Country (2019-2024)
7.1.2 Europe Warfarin Revenue by Country (2019-2024)
7.2 Europe Warfarin Sales by Type
7.3 Europe Warfarin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Warfarin by Country
8.1.1 Middle East & Africa Warfarin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Warfarin Revenue by Country (2019-2024)
8.2 Middle East & Africa Warfarin Sales by Type
8.3 Middle East & Africa Warfarin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Warfarin
10.3 Manufacturing Process Analysis of Warfarin
10.4 Industry Chain Structure of Warfarin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Warfarin Distributors
11.3 Warfarin Customer
12 World Forecast Review for Warfarin by Geographic Region
12.1 Global Warfarin Market Size Forecast by Region
12.1.1 Global Warfarin Forecast by Region (2025-2030)
12.1.2 Global Warfarin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Warfarin Forecast by Type
12.7 Global Warfarin Forecast by Application
13 Key Players Analysis
13.1 Qilu Pharma
13.1.1 Qilu Pharma Company Information
13.1.2 Qilu Pharma Warfarin Product Portfolios and Specifications
13.1.3 Qilu Pharma Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Qilu Pharma Main Business Overview
13.1.5 Qilu Pharma Latest Developments
13.2 Sine Pharma (Shanghai Pharma)
13.2.1 Sine Pharma (Shanghai Pharma) Company Information
13.2.2 Sine Pharma (Shanghai Pharma) Warfarin Product Portfolios and Specifications
13.2.3 Sine Pharma (Shanghai Pharma) Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sine Pharma (Shanghai Pharma) Main Business Overview
13.2.5 Sine Pharma (Shanghai Pharma) Latest Developments
13.3 Beijing Jialin Pharmaceutical
13.3.1 Beijing Jialin Pharmaceutical Company Information
13.3.2 Beijing Jialin Pharmaceutical Warfarin Product Portfolios and Specifications
13.3.3 Beijing Jialin Pharmaceutical Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Beijing Jialin Pharmaceutical Main Business Overview
13.3.5 Beijing Jialin Pharmaceutical Latest Developments
13.4 Henan Zhongjie Pharma
13.4.1 Henan Zhongjie Pharma Company Information
13.4.2 Henan Zhongjie Pharma Warfarin Product Portfolios and Specifications
13.4.3 Henan Zhongjie Pharma Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Henan Zhongjie Pharma Main Business Overview
13.4.5 Henan Zhongjie Pharma Latest Developments
13.5 Shanghai Xudong Haipu Pharmaceutical (SunRise)
13.5.1 Shanghai Xudong Haipu Pharmaceutical (SunRise) Company Information
13.5.2 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Product Portfolios and Specifications
13.5.3 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai Xudong Haipu Pharmaceutical (SunRise) Main Business Overview
13.5.5 Shanghai Xudong Haipu Pharmaceutical (SunRise) Latest Developments
13.6 Amneal Pharma
13.6.1 Amneal Pharma Company Information
13.6.2 Amneal Pharma Warfarin Product Portfolios and Specifications
13.6.3 Amneal Pharma Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amneal Pharma Main Business Overview
13.6.5 Amneal Pharma Latest Developments
13.7 TEVA (Barr, PLIVA)
13.7.1 TEVA (Barr, PLIVA) Company Information
13.7.2 TEVA (Barr, PLIVA) Warfarin Product Portfolios and Specifications
13.7.3 TEVA (Barr, PLIVA) Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 TEVA (Barr, PLIVA) Main Business Overview
13.7.5 TEVA (Barr, PLIVA) Latest Developments
13.8 Cipla (InvaGen)
13.8.1 Cipla (InvaGen) Company Information
13.8.2 Cipla (InvaGen) Warfarin Product Portfolios and Specifications
13.8.3 Cipla (InvaGen) Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Cipla (InvaGen) Main Business Overview
13.8.5 Cipla (InvaGen) Latest Developments
13.9 Orion Corporation Orion Pharma
13.9.1 Orion Corporation Orion Pharma Company Information
13.9.2 Orion Corporation Orion Pharma Warfarin Product Portfolios and Specifications
13.9.3 Orion Corporation Orion Pharma Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Orion Corporation Orion Pharma Main Business Overview
13.9.5 Orion Corporation Orion Pharma Latest Developments
13.10 BRISTOL MYERS SQUIBB
13.10.1 BRISTOL MYERS SQUIBB Company Information
13.10.2 BRISTOL MYERS SQUIBB Warfarin Product Portfolios and Specifications
13.10.3 BRISTOL MYERS SQUIBB Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BRISTOL MYERS SQUIBB Main Business Overview
13.10.5 BRISTOL MYERS SQUIBB Latest Developments
13.11 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
13.11.1 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Information
13.11.2 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Product Portfolios and Specifications
13.11.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Main Business Overview
13.11.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Latest Developments
13.12 Zydus Pharmaceuticals (USA) Inc
13.12.1 Zydus Pharmaceuticals (USA) Inc Company Information
13.12.2 Zydus Pharmaceuticals (USA) Inc Warfarin Product Portfolios and Specifications
13.12.3 Zydus Pharmaceuticals (USA) Inc Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Zydus Pharmaceuticals (USA) Inc Main Business Overview
13.12.5 Zydus Pharmaceuticals (USA) Inc Latest Developments
13.13 Taro Pharmaceutical Industries Ltd.
13.13.1 Taro Pharmaceutical Industries Ltd. Company Information
13.13.2 Taro Pharmaceutical Industries Ltd. Warfarin Product Portfolios and Specifications
13.13.3 Taro Pharmaceutical Industries Ltd. Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Taro Pharmaceutical Industries Ltd. Main Business Overview
13.13.5 Taro Pharmaceutical Industries Ltd. Latest Developments
13.14 IPCA LABS LTD
13.14.1 IPCA LABS LTD Company Information
13.14.2 IPCA LABS LTD Warfarin Product Portfolios and Specifications
13.14.3 IPCA LABS LTD Warfarin Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 IPCA LABS LTD Main Business Overview
13.14.5 IPCA LABS LTD Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂